|
| 37292686 | Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. | Res Sq | 2023 |
| 35976058 | Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. | Neuro Oncol | 2023 |
| 36239925 | Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. | Neuro Oncol | 2023 |
| 36215167 | Neurological applications of belzutifan in von Hippel-Lindau disease. | Neuro-Oncology | 2023 |
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 36399711 | Determining venous thromboembolism risk in patients with adult-type diffuse glioma. | Blood | 2023 |
| 37580817 | Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis. | Acta Neuropathol Commun | 2023 |
| 37725593 | Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence. | Clin Cancer Res | 2023 |
| 37476329 | Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. | Neurooncol Adv | 2023 |
| 36778274 | Clinical outcomes for pleomorphic xanthoastrocytoma patients: an institutional experience. | Res Sq | 2023 |
| 37027168 | From the ER to the OR: Initial Evaluation of Primary Central Nervous System Lymphoma. | | 2023 |
| 36959545 | Discovery of novel glioma serum biomarkers by proximity extension assay. | Clin Proteomics | 2023 |
| 36638329 | Reconciling the Contemporary Molecular Diagnosis of Glioblastoma With Past Clinical Trial Data. | | 2023 |
| 37132598 | Redox Homeostasis and Beyond: The Role of Wild-Type Isocitrate Dehydrogenases for the Pathogenesis of Glioblastoma. | | 2023 |
| 36759014 | IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM. | J Immunother Cancer | 2023 |
| 36700952 | Variant allelic frequency of driver mutations predicts success of genomic DNA methylation classification in central nervous system tumors. | Acta Neuropathol | 2023 |
| 36634606 | NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. | J Natl Compr Canc Netw | 2023 |
| 37252795 | The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma. | JCI Insight | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 37104042 | Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. | J Clin Invest | 2023 |
| 37100086 | Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review. | Neuro Oncol | 2023 |
| 36988488 | Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis. | Neuro Oncol | 2023 |
| 37532182 | ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients. | Mod Pathol | 2023 |
| 37509316 | Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review. | Cancers (Basel) | 2023 |
| 37503127 | NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. | bioRxiv | 2023 |
| 35103816 | High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. | Acta Neuropathol | 2022 |
| 35525907 | Tumor-associated alterations in white matter connectivity have prognostic significance in MGMT-unmethylated glioblastoma. | Journal of Neuro-Oncology | 2022 |
| 36103817 | SerpinB3 drives cancer stem cell survival in glioblastoma. | Cell Reports | 2022 |
| 36233828 | Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy. | Journal of Clinical Medicine | 2022 |
| 35578106 | Major Features of the 2021 WHO Classification of CNS Tumors. | Neurotherapeutics | 2022 |
| 35552677 | Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma. | Clin Cancer Res | 2022 |
| 35729337 | Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. | Nat Rev Neurol | 2022 |
| 35605901 | Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors. | J Mol Diagn | 2022 |
| 36428586 | Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts. | Cancers (Basel) | 2022 |
| 36410047 | Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma. | Journal of Medicinal Chemistry | 2022 |
| 35534729 | Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. | Nature Metabolism | 2022 |
| 36497370 | Clinical Management of Supratentorial Non-Skull Base Meningiomas. | Cancers (Basel) | 2022 |
| 35062028 | The Frequency of Focal Cortical Dysplasia-Like Histologic Features Near Adult-Type Diffuse Gliomas. | Journal of Neuropathology and Experimental Neurology | 2022 |
| 35316217 | Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. | JCI Insight | 2022 |
| 34865083 | Next-Generation Sequencing of a Glioblastoma with True Epithelial Differentiation. | J Neuropathol Exp Neurol | 2022 |
| 35149861 | Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. | Nat Cancer | 2022 |
| 35134075 | The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma. | PLoS ONE | 2022 |
| 35128400 | Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation. | Neurooncol Adv | 2022 |
| 35104243 | PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis. | JCI insight | 2022 |
| 34691054 | CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. | Front Immunol | 2021 |
| 33539787 | PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. | Mol Cell | 2021 |
| 33855339 | De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. | Brain | 2021 |
| 33692132 | A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. | Sci Transl Med | 2021 |
| 34118826 | The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results. | Chin Clin Oncol | 2021 |
| 33851151 | Longitudinal Study of Boxing Therapy in Parkinson's Disease, Including Adverse Impacts of the COVID-19 Lockdown. | | 2021 |